Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finance Watch: Mysterious Gossamer Raises $100m As VC Deals Surge Ahead of J.P. Morgan

Executive Summary

Gossamer Bio, led by former Receptos CEO Faheem Hasnain and CMO Sheila Gujrathi, revealed $100m in seed and Series A funding during a week in which 17 companies revealed VC rounds totaling $891.2m, giving them good news to discuss during the J.P. Morgan Healthcare conference.

Advertisement

Related Content

Finance Watch: Investors Can't Get Enough Of NASH, Including Start-Ups With Novel Drugs
Finance Watch: Rough US Stock Market Doesn't Stop Biopharma IPOs As Six More Go Public
Finance Watch: A Plethora Of Big Rounds, Led By Gossamer's $230m Series B
Finance Watch: Semma Raises $114m As VC Funding Keeps Up Brisk Pace
Pipeline Watch: Kisqali, SI-6603, Cosentyx Phase III Readouts
Biogen/Ionis’s Spinraza Approved; Second Antisense Drug For Neurodegeneration In 2016
DMD Pipeline: After Sarepta’s First-Ever Approval, Are Combinations Next?
Allergan’s RetroSense Buy Marks Move Into Gene Therapy
Scholar Rock Secures $36m Investment And Janssen IO Option
Celgene diversifies with $7.2bn Receptos buy

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100158

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel